The Arandjelovic laboratory research focus is on cell clearance in inflammatory disease, using rheumatoid arthritis (RA) and multiple sclerosis (MS) as model systems

Research Summary

Research in the Arandjelovic Lab is focused on the process of apoptotic (dying) cell clearance, also known as efferocytosis (from Greek effero, meaning to “bury” or “take to the grave”). Apoptotic cells are frequently observed at sites of ongoing inflammation, and their inefficient removal can lead to secondary necrosis and the release of their cellular contents, which can further fuel the inflammatory process. At the same tme, metabolites released by apoptotic cells, also referred to as ‘good-bye’ signals, elicit cellular responses that actively promote resolution of inflammation and tissue regeneration, which is essential for the maintenance of immune ‘silence’.

Learn More

Current Projects

Function of the engulfment regulator ELMO1 in inflammation

Learn More

ELMO1 function in innate immunity

Learn More

Efferocytosis modulation in acute and chronic inflammatory disease

Learn More

Lab Members

Meet the Team